Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers
- 22 July 2021
- book chapter
- research article
- Published by Springer Science and Business Media LLC
- Vol. 1347, 163-181
- https://doi.org/10.1007/5584_2021_648
Abstract
Breast cancer is the leading cancer type diagnosed among women in the world. Unfortunately, drug resistance to current breast cancer chemotherapeutics remains the main challenge for a higher survival rate. The recent progress in the nanoparticle platforms and distinct features of nanoparticles that enhance the efficacy of therapeutic agents, such as improved delivery efficacy, increased intracellular cytotoxicity, and reduced side effects, hold great promise to overcome the observed drug resistance. Currently, multifaceted investigations are probing the resistance mechanisms associated with clinical drugs, and identifying new breast cancer-associated molecular targets that may lead to improved therapeutic approaches with the nanoparticle platforms. Nanoparticle platforms including siRNA, antibody-specific targeting and the role of nanoparticles in cellular processes and their effect on breast cancer were discussed in this article. Keywords Breast cancer Drug resistance Therapeutic targets/delivery (new discoveries)Keywords
This publication has 168 references indexed in Scilit:
- Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for ChemoresistanceJournal of Investigative Dermatology, 2012
- Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomasBritish Journal of Cancer, 2012
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cellsCell Death & Disease, 2012
- Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in CancerMolecular Therapy, 2011
- Aromatase, aromatase inhibitors, and breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Biodegradable luminescent porous silicon nanoparticles for in vivo applicationsNature Materials, 2009
- Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherinThe Journal of Experimental Medicine, 2007
- The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisOncogene, 2007
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences of the United States of America, 2003